These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36044156)

  • 1. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
    MacKinnon L; Socías ME; Bardwell G
    J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study.
    Collins AB; Boyd J; Hayashi K; Cooper HLF; Goldenberg S; McNeil R
    Int J Drug Policy; 2020 Feb; 76():102641. PubMed ID: 31887644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care embedded within permanent supportive housing for people who use substances: A qualitative study examining healthcare access in Vancouver, Canada.
    MacKinnon L; Kerman N; Socías ME; Brar R; Bardwell G
    Health Soc Care Community; 2022 Nov; 30(6):e5062-e5073. PubMed ID: 35852403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G; Bowles JM; Mansoor M; Werb D; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):14. PubMed ID: 36869358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
    Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.
    Fleming T; Boyd J; Gagnon M; Kerr T; McNeil R
    Int J Drug Policy; 2024 Jun; 128():104444. PubMed ID: 38754243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada.
    Moe J; Chavez T; Marr C; Cameron F; Feldman-Kiss D; Wang YE; Xavier JC; Mamdani Z; Purssell RA; Salmon A; Buxton JA
    Harm Reduct J; 2024 Feb; 21(1):45. PubMed ID: 38378610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
    Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safer opioid supply: qualitative program evaluation.
    Haines M; O'Byrne P
    Harm Reduct J; 2023 Apr; 20(1):53. PubMed ID: 37081500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling the overdose crisis: The role of safe supply.
    Ivsins A; Boyd J; Beletsky L; McNeil R
    Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA.
    Paradise RK; Desmarais J; O'Malley SE; Hoyos-Cespedes A; Nurani A; Walley AY; Clarke J; Taylor S; Dooley D; Bazzi AR; Kimmel SD
    Int J Drug Policy; 2023 Sep; 119():104127. PubMed ID: 37523844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T; Mniszak C; Jenkins E; Fast D; Knight R
    Harm Reduct J; 2020 Mar; 17(1):23. PubMed ID: 32228646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.